Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

Anna Kreutzman, Taina Jaatinen, Dario Greco, Emmi Vakkila, Johan Richter, Marja Ekblom, Henrik Hjorth-Hansen, Leif Stenke, Teresa Melo, Ron Paquette, Ruth Seggewiss-Bernhardt, Agnes Guerci-Bresler, Alexis Talbot, Jean Michel Cayuela, Francois-Xavier Mahon, Kimmo Porkka, Jeff Lipton, Jukka Partanen, Philippe Rousselot, Satu Mustjoki

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalExperimental Hematology
Volume40
Issue number11
Pages (from-to)906-913
Number of pages8
ISSN0301-472X
DOIs
Publication statusPublished - 1 Nov 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 Internal medicine

Cite this

Kreutzman, Anna ; Jaatinen, Taina ; Greco, Dario ; Vakkila, Emmi ; Richter, Johan ; Ekblom, Marja ; Hjorth-Hansen, Henrik ; Stenke, Leif ; Melo, Teresa ; Paquette, Ron ; Seggewiss-Bernhardt, Ruth ; Guerci-Bresler, Agnes ; Talbot, Alexis ; Cayuela, Jean Michel ; Mahon, Francois-Xavier ; Porkka, Kimmo ; Lipton, Jeff ; Partanen, Jukka ; Rousselot, Philippe ; Mustjoki, Satu. / Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia. In: Experimental Hematology. 2012 ; Vol. 40, No. 11. pp. 906-913.
@article{e011b3a0f1da492487b38b03b51444ef,
title = "Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia",
keywords = "3121 Internal medicine",
author = "Anna Kreutzman and Taina Jaatinen and Dario Greco and Emmi Vakkila and Johan Richter and Marja Ekblom and Henrik Hjorth-Hansen and Leif Stenke and Teresa Melo and Ron Paquette and Ruth Seggewiss-Bernhardt and Agnes Guerci-Bresler and Alexis Talbot and Cayuela, {Jean Michel} and Francois-Xavier Mahon and Kimmo Porkka and Jeff Lipton and Jukka Partanen and Philippe Rousselot and Satu Mustjoki",
year = "2012",
month = "11",
day = "1",
doi = "10.1016/j.exphem.2012.07.007",
language = "English",
volume = "40",
pages = "906--913",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",
number = "11",

}

Kreutzman, A, Jaatinen, T, Greco, D, Vakkila, E, Richter, J, Ekblom, M, Hjorth-Hansen, H, Stenke, L, Melo, T, Paquette, R, Seggewiss-Bernhardt, R, Guerci-Bresler, A, Talbot, A, Cayuela, JM, Mahon, F-X, Porkka, K, Lipton, J, Partanen, J, Rousselot, P & Mustjoki, S 2012, 'Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia', Experimental Hematology, vol. 40, no. 11, pp. 906-913. https://doi.org/10.1016/j.exphem.2012.07.007

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia. / Kreutzman, Anna; Jaatinen, Taina; Greco, Dario; Vakkila, Emmi; Richter, Johan; Ekblom, Marja; Hjorth-Hansen, Henrik; Stenke, Leif; Melo, Teresa; Paquette, Ron; Seggewiss-Bernhardt, Ruth; Guerci-Bresler, Agnes; Talbot, Alexis; Cayuela, Jean Michel; Mahon, Francois-Xavier; Porkka, Kimmo; Lipton, Jeff; Partanen, Jukka; Rousselot, Philippe; Mustjoki, Satu.

In: Experimental Hematology, Vol. 40, No. 11, 01.11.2012, p. 906-913.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

AU - Kreutzman, Anna

AU - Jaatinen, Taina

AU - Greco, Dario

AU - Vakkila, Emmi

AU - Richter, Johan

AU - Ekblom, Marja

AU - Hjorth-Hansen, Henrik

AU - Stenke, Leif

AU - Melo, Teresa

AU - Paquette, Ron

AU - Seggewiss-Bernhardt, Ruth

AU - Guerci-Bresler, Agnes

AU - Talbot, Alexis

AU - Cayuela, Jean Michel

AU - Mahon, Francois-Xavier

AU - Porkka, Kimmo

AU - Lipton, Jeff

AU - Partanen, Jukka

AU - Rousselot, Philippe

AU - Mustjoki, Satu

PY - 2012/11/1

Y1 - 2012/11/1

KW - 3121 Internal medicine

U2 - 10.1016/j.exphem.2012.07.007

DO - 10.1016/j.exphem.2012.07.007

M3 - Article

VL - 40

SP - 906

EP - 913

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 11

ER -